HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection against Helicobacter pylori infection by intestinal immunisation with a 50/52-kDa subunit protein.

Abstract
A mouse model of Helicobacter pylori infection was used to evaluate the vaccine antigen potential of the citrate synthase homologue protein purified from the H. pylori NCTC 11637 strain. Mice were immunised with the protein by intra-Peyer's patch immunisation. This route gives maximal intestinal immunisation and was used to screen oral vaccine candidate antigens without the added complication of simultaneously testing oral delivery systems. Two weeks post-immunisation mice were infected with Sydney strain H. pylori and 4 weeks after infection the mice were killed and the level of H. pylori infection in the stomach determined. Pre-immunisation with the 50/52-kDa protein led to a 84-91% reduction in H. pylori infection compared to unimmunised controls.
AuthorsM L Dunkley, S J Harris, R J McCoy, M J Musicka, F M Eyers, L G Beagley, P J Lumley, K W Beagley, R L Clancy
JournalFEMS immunology and medical microbiology (FEMS Immunol Med Microbiol) Vol. 24 Issue 2 Pg. 221-5 (Jun 1999) ISSN: 0928-8244 [Print] England
PMID10378424 (Publication Type: Journal Article)
Chemical References
  • Antigens, Bacterial
  • Bacterial Vaccines
  • Citrate (si)-Synthase
Topics
  • Animals
  • Antigens, Bacterial (immunology, isolation & purification)
  • Bacterial Vaccines (administration & dosage, immunology)
  • Citrate (si)-Synthase (chemistry, immunology)
  • Disease Models, Animal
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Helicobacter Infections (microbiology, prevention & control)
  • Helicobacter pylori (enzymology, immunology, isolation & purification)
  • Mice
  • Mice, Inbred C57BL
  • Peyer's Patches (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: